Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 22, 20 December 2023
Open
Access | Article
Research progress and preventive strategy of HPV and cervical cancer and other related cancers
* Author to whom correspondence should be addressed.
Abstract
This paper comprehensively reviews the research on the relationship between HPV and cervical cancer and other cancers and expounds the pathogenesis of cancer caused by HPV and its negative impact on the body. The screening methods and their effectiveness are reviewed, and the relevant research and latest developments of vaccines are summarized. First, the basic knowledge about HPV (including the structure and typing of the virus and the mechanism of infection of the virus) is introduced, and the screening method and its effectiveness are explored. Furthermore, the relationship between cervical cancer and HPV infection (including the mechanism of occurrence, the type of virus that causes cervical cancer, and the characteristics after infection) is discussed emphatically. Subsequently, the relationship between HPV infection and other cancers (including the mechanism of infection, classification and post-infection characteristics) was further explored, such as oral cancer, anal cancer, and reproductive organ cancer (except cervical cancer that has been introduced above). In the end, the current research results on HPV prevention and the challenges to be met from the current point of view are summarized, and the outlook and some suggestions for the research direction of future vaccines are made.
Keywords
HPV, vaccines, cancer
References
1. Centers for Disease Control and Prevention. “STD Facts - Human Papillomavirus (HPV).” Centers for Disease Control and Prevention, 19 Jan. 2021
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. “Human Papillomavirus (HPV) Infection.” Nih.gov, International Agency for Research on Cancer, 2007.
3. Ntuli, L., Mtshali, A., Mzobe, G., Liebenberg, L. J., & Ngcapu, S. (2022). Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection. Frontiers in cellular and infection microbiology, 12, 927131.
4. Gutiérrez-Hoya, A., & Soto-Cruz, I. (2020). Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins. Cells, 9(10), 2297.
5. Revathidevi, S., Murugan, A. K., Nakaoka, H., Inoue, I., & Munirajan, A. K. (2021). APOBEC: A molecular driver in cervical cancer pathogenesis. Cancer letters, 496, 104–116.
6. Yuan, Y., Cai, X., Shen, F., & Ma, F. (2021). HPV post-infection microenvironment and cervical cancer. Cancer letters, 497, 243–254.
7. National Cancer Institute. “Cancer of the Cervix Uteri - Cancer Stat Facts.” SEER, 2018, seer.cancer.gov/statfacts/html/cervix.html. Accessed 9 June 2023.
8. National Cancer Institute. “HPV and Cancer.” National Cancer Institute, Cancer.gov, 31 Jan. 2023, www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-can-cer. Accessed 9 June 2023.
9. Omland, S. H., Ahlström, M. G., Gerstoft, J., Pedersen, G., Mohey, R., Pedersen, C., Kronborg, G., Larsen, C. S., Kvinesdal, B., Gniadecki, R., Obel, N., & Omland, L. H. (2018). Risk of skin cancer in patients with HIV: A Danish nationwide cohort study. Journal of the American Academy of Dermatology, 79(4), 689–695.
10. Szymonowicz, K. A., & Chen, J. (2020). Biological and clinical aspects of HPV-related cancers. Cancer biology & medicine, 17(4), 864–878.
11. Kamolratanakul, S., & Pitisuttithum, P. (2021). Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer. Vaccines, 9(12), 1413.
12. de Oliveira, C. M., Fregnani, J. H. T. G., & Villa, L. L. (2019). HPV Vaccine: Updates and Highlights. Acta cytologica, 63(2), 159–168.
13. Wang, R., Pan, W., Jin, L., Huang, W., Li, Y., Wu, D., Gao, C., Ma, D., & Liao, S. (2020). Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer letters, 471, 88–102.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
- ISBN (Print)
- 978-1-83558-217-6
- ISBN (Online)
- 978-1-83558-218-3
- Published Date
- 20 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/22/20230935
- Copyright
- 20 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited